Skip to main content
. 2017 May 15;7:1898. doi: 10.1038/s41598-017-01721-4

Figure 2.

Figure 2

TRAIL protects against lipid uptake in HepG2 cells. (a) Palmitate increases triglyceride uptake in HepG2 cells over 5 days as measured by Oil red O. (b) Inflammation and (c) fibrotic markers are increased in HepG2 cells in response to palmitate over 5 d. (d) mRNA expression for TRAIL is significantly reduced with lipid uptake over time. (e) DR4 and (f) DR5 expression in response to palmitate. (g) 1 ng/ml TRAIL inhibits palmitate-induced oil red O in HepG2 cells at 24 h compared to the vehicle PBS. Control, untreated cells; n = 3–4/treatment. mRNA expression was normalized to GAPDH. Results are expressed as mean ± SEM; ANOVA; *p < 0.05, **p < 0.01, ***p < 0.001 and ****p < 0.0001.